Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9

Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9

Dyslipidemia is listed among important cardiovascular disease risk factors. Treating lipid disorders is difficult, and achieving desirable levels of LDL-cholesterol (LDL-C) is essential in both the secondary and primary prevention of cardiovascular disease. For many years, statins became the basis o...

Full description

Bibliographic Details
Main Authors: Łukasz Wołowiec, Joanna Osiak, Anna Wołowiec, Aleksandra Wijata, Elżbieta Grześk, Mariusz Kozakiewicz, Joanna Banach, Alicja Nowaczyk, Jacek Nowaczyk, Grzegorz Grześk
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Pharmaceutics
Subjects:
inclisiran
PCSK9
siRNA
dyslipidemia
atherosclerosis
Online Access:https://www.mdpi.com/1999-4923/15/2/323

Internet

https://www.mdpi.com/1999-4923/15/2/323

Similar Items